Cargando…

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease

Detalles Bibliográficos
Autores principales:	Bechman, Katie, Galloway, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870320/ https://www.ncbi.nlm.nih.gov/pubmed/36714041 http://dx.doi.org/10.1016/S2665-9913(23)00031-0

Ejemplares similares

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Evaluating COVID-19 vaccines in the real world
por: Mills, Edward J, et al.
Publicado: (2022)

Real-world effectiveness of oral antivirals for COVID-19
por: Burdet, Charles, et al.
Publicado: (2022)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

The immunosuppressed traveler: infection risks with autoimmunity and immunosuppression, vaccinations, and general travel advice
por: Allen, Victoria, et al.
Publicado: (2020)

Symptom study app provides real-world data on COVID-19 vaccines
por: Drury, Ruth E, et al.
Publicado: (2021)

Implications of systemic racism in emergency medical services: On prehospital bias and complicity
por: Ventura, Christian Angelo I., et al.
Publicado: (2022)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Real World Evidence: methodological issues and opportunities from the European Health Data Space
por: Kympouropoulos, Stelios
Publicado: (2023)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

Real-world use of nirmatrelvir–ritonavir: who benefits?
por: Molina, Kyle C, et al.
Publicado: (2023)

Naturalizing psychopathology—towards a quantitative real-world psychiatry
por: Lahnakoski, Juha M., et al.
Publicado: (2021)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

After COVID-19, a future for the world's children?
Publicado: (2020)

The World Bank COVID-19 response: Politics as usual?
por: Kilby, Christopher, et al.
Publicado: (2021)

Renin–angiotensin system inhibitors and COVID-19: overwhelming evidence against an association
por: de Abajo, Francisco J
Publicado: (2021)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Impact of autoimmune risk alleles on the immune system
por: Ray, John P, et al.
Publicado: (2015)

Vaccination prevents hospitalisations of children and adolescents. A real-world analysis
por: Bolcatto, Pablo G.
Publicado: (2022)

Managing COVID-19 importation risks in a heterogeneous world
por: Cauchemez, Simon, et al.
Publicado: (2021)

Long COVID: an estrogen-associated autoimmune disease?
por: Ortona, Elena, et al.
Publicado: (2021)

From Data to Wisdom: Biomedical Knowledge Graphs for Real-World Data Insights
por: Hänsel, Katrin, et al.
Publicado: (2023)

What prevents us from reusing medical real-world data in research
por: Gehrmann, Julia, et al.
Publicado: (2023)

COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
por: Lakota, Katja, et al.
Publicado: (2021)

COVID-19 and suicide: Evidence from Japan
por: Spittal, Matthew J.
Publicado: (2022)

COVID-19 in pregnancy: evidence from LMICs
por: Costa, Maria Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9r4j12r8hi6fom7ph3otbtt7ra